Abstract Details

Title Specificity and Potential Pathogenicity of Antibodies to a Central Nervous System (CNS) Autoantigen in Multiple Sclerosis Patients

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 087

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Michael C. Levin, MD, FAAN (University of Saskatchewan)	Dr. Levin has received personal compensation for serving as an employee of Merck. Dr. Levin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Levin has received research support from CIHR.
	No disclosure on file
Lidia Gardner, PhD, EMBA (Novartis Pharmaceutical Corporation)	Dr. Gardner has stock in EMD Serono.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Cedric S. Raine, PhD, DSc (Albert Einstein Coll of Med)	No disclosure on file
	No disclosure on file

��ɫ��